US pharma giants Pfizer, Johnson & Johnson, and Novavax could be among the potential gainers from the government’s decision on
Tuesday to fast-track approvals for foreign-produced Covid-19 vaccines authorised by major global regulators.The rollout of vaccines from Pfizer and J&J could take a few months as the companies are yet to decide their strategies Pfizer could face issues due to limited manufacturing capacity.
Support Ethical Journalism. Support The Dispatch
The Dispatch is a sincere effort in ethical journalism. Truth, Accuracy, Independence, Fairness, Impartiality, Humanity and Accountability are key elements of our editorial policy. But we are still not able to generate great stories, because we don’t have adequate resources. As more and more media falls into corporate and political control, informed citizens across the world are funding independent journalism initiatives. Here is your chance to support your local media startup and help independent journalism survive. Click the link below to make a payment of your choice and be a stakeholder in public spirited journalism